BioSpace News Archive

DWK Life Sciences, the world’s largest manufacturer of precision labware, introduces WHEATON® CompletePAK, a customizable collection of commonly used vials, stoppers and seals that are shipped sterile and delivered ready-to-use with USP certifications for traceability

Imbed Biosciences Inc. (Imbed), a privately held biotech company emerging as a leader in the development of advanced therapies for burns, chronic ulcers and surgical wounds, announced today that it has closed its Series A Preferred Stock equity financing, which was expanded to $4 million due to investor demand.

Surgical Innovation Associates (SIA), a medical device spin-out from Northwestern University, announced today it secured a $2M grant from the National Cancer Institute (NCI), the largest institute within National Institutes of Health (NIH), via the Small Business Innovation Research (SBIR) program

OptraHEALTH®, creators of GeneFAX™, the conversational AI platform trained on genetics, and InformedDNA®, the nation’s largest independent provider of genetics experts, today announced that they will partner to offer access to InformedDNA’s board-certified genetic counselors through GeneFAX’s AI-enabled CounselorConnect platform.

Photocure ASA., (OSE: PHO), The United States Centers for Medicare and Medicaid Services (CMS) has released its Final Rule maintaining the reimbursement code (A Code) for Cysview when used in hospital outpatient and other sites of care and improved the complexity adjustment codes.

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the first round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas.

Integrated CBD, the preeminent producer and supplier of organically grown and sustainably produced phytocannabinoids, has announced its conference schedule for November.

Patient engagement pioneer and 30-year point-of-care marketing leader PatientPoint® dominated the 2019 National Health Information Awards (NHIAs) with 80 awards—more than any other organization for the eighth consecutive year.

Today, the U.S. Food and Drug Administration authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology.

Medopad, a fast-growing healthtech AI startup headquartered in London, has earned investment in a funding round led by Leaps by Bayer in to further develop its digital health platform.